Driven Brands to Present at the William Blair Growth Stock Conference
CHARLOTTE, N.C.–(BUSINESS WIRE)–Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today announced that it will present... Read more.
enGene to Present at the Jefferies Global Healthcare Conference
BOSTON & MONTREAL–(BUSINESS WIRE)–enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company... Read more.
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
– Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 – – Ellen James, Director, Clinical Development, to... Read more.
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Acceptance based on results from the pivotal Phase 3 CCTG IND.227/KEYNOTE-483 trial, which demonstrated a statistically significant improvement in overall survival... Read more.
SoSafe Announces New Executive Advisors as Company Expands Category and Product Leadership
COLOGNE, Germany–(BUSINESS WIRE)–#Cyber–SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed four new... Read more.
Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage... Read more.
CareDx to Participate in Upcoming Investor Conferences
BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery,... Read more.
Chewy Announces First Quarter 2024 Financial Results
PLANTATION, Fla.–(BUSINESS WIRE)–Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released... Read more.
VUZE Medical Announces U.S. FDA 510(K) Clearance for Second-Generation Software-Based 3D Guidance System for Spine Surgery
VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR — no cameras, markers, references... Read more.
Blackstone Real Estate Sells Turtle Bay Resort
Inclusive of recent land sale, sale proceeds total $768 million NEW YORK–(BUSINESS WIRE)–Blackstone Real Estate today announced that it has reached an... Read more.